MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele. 2010

Austin T Thiel, and Peter Blessington, and Tao Zou, and Danielle Feather, and Xinjiang Wu, and Jizhou Yan, and Hui Zhang, and Zuguo Liu, and Patricia Ernst, and Gary A Koretzky, and Xianxin Hua
Abramson Family Cancer Research Institute, Department of Cancer Biology, University of Pennsylvania, Philadelphia, 19104, USA.

Oncogenic fusion proteins are capable of initiating tumorigenesis, but the role of their wild-type counterparts in this process is poorly understood. The mixed lineage leukemia (MLL) gene undergoes chromosomal translocations, resulting in the formation of oncogenic MLL fusion proteins (MLL-FPs). Here, we show that menin recruits both wild-type MLL and oncogenic MLL-AF9 fusion protein to the loci of HOX genes to activate their transcription. Wild-type MLL not only catalyzes histone methylation at key target genes but also controls distinct MLL-AF9-induced histone methylation. Notably, the wild-type Mll allele is required for MLL-AF9-induced leukemogenesis and maintenance of MLL-AF9-transformed cells. These findings suggest an essential cooperation between an oncogene and its wild-type counterpart in MLL-AF9-induced leukemogenesis.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008745 Methylation Addition of methyl groups. In histo-chemistry methylation is used to esterify carboxyl groups and remove sulfate groups by treating tissue sections with hot methanol in the presence of hydrochloric acid. (From Stedman, 25th ed) Methylations
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D006657 Histones Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each. Histone,Histone H1,Histone H1(s),Histone H2a,Histone H2b,Histone H3,Histone H3.3,Histone H4,Histone H5,Histone H7
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014178 Translocation, Genetic A type of chromosome aberration characterized by CHROMOSOME BREAKAGE and transfer of the broken-off portion to another location, often to a different chromosome. Chromosomal Translocation,Translocation, Chromosomal,Chromosomal Translocations,Genetic Translocation,Genetic Translocations,Translocations, Chromosomal,Translocations, Genetic
D015514 Oncogene Proteins, Fusion The GENETIC TRANSLATION products of the fusion between an ONCOGENE and another gene. The latter may be of viral or cellular origin. Chimeric Oncogene Proteins,Chimeric Proteins, Oncogene,Fusion Proteins, Oncogene,Oncogene Fusion Proteins,Oncogene Proteins, Chimeric,Fusion Oncogene Proteins,Oncogene Chimeric Proteins,Proteins, Chimeric Oncogene,Proteins, Fusion Oncogene,Proteins, Oncogene Chimeric,Proteins, Oncogene Fusion
D015973 Gene Expression Regulation, Leukemic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in leukemia. Leukemic Gene Expression Regulation,Regulation of Gene Expression, Leukemic,Regulation, Gene Expression, Leukemic

Related Publications

Austin T Thiel, and Peter Blessington, and Tao Zou, and Danielle Feather, and Xinjiang Wu, and Jizhou Yan, and Hui Zhang, and Zuguo Liu, and Patricia Ernst, and Gary A Koretzky, and Xianxin Hua
January 2021, Frontiers in oncology,
Austin T Thiel, and Peter Blessington, and Tao Zou, and Danielle Feather, and Xinjiang Wu, and Jizhou Yan, and Hui Zhang, and Zuguo Liu, and Patricia Ernst, and Gary A Koretzky, and Xianxin Hua
October 2016, Oncotarget,
Austin T Thiel, and Peter Blessington, and Tao Zou, and Danielle Feather, and Xinjiang Wu, and Jizhou Yan, and Hui Zhang, and Zuguo Liu, and Patricia Ernst, and Gary A Koretzky, and Xianxin Hua
November 2011, Cancer cell,
Austin T Thiel, and Peter Blessington, and Tao Zou, and Danielle Feather, and Xinjiang Wu, and Jizhou Yan, and Hui Zhang, and Zuguo Liu, and Patricia Ernst, and Gary A Koretzky, and Xianxin Hua
June 2011, Blood,
Austin T Thiel, and Peter Blessington, and Tao Zou, and Danielle Feather, and Xinjiang Wu, and Jizhou Yan, and Hui Zhang, and Zuguo Liu, and Patricia Ernst, and Gary A Koretzky, and Xianxin Hua
April 2017, Cancer research,
Austin T Thiel, and Peter Blessington, and Tao Zou, and Danielle Feather, and Xinjiang Wu, and Jizhou Yan, and Hui Zhang, and Zuguo Liu, and Patricia Ernst, and Gary A Koretzky, and Xianxin Hua
July 2000, Human molecular genetics,
Austin T Thiel, and Peter Blessington, and Tao Zou, and Danielle Feather, and Xinjiang Wu, and Jizhou Yan, and Hui Zhang, and Zuguo Liu, and Patricia Ernst, and Gary A Koretzky, and Xianxin Hua
January 2014, Molecular & cellular oncology,
Austin T Thiel, and Peter Blessington, and Tao Zou, and Danielle Feather, and Xinjiang Wu, and Jizhou Yan, and Hui Zhang, and Zuguo Liu, and Patricia Ernst, and Gary A Koretzky, and Xianxin Hua
April 2022, Leukemia,
Austin T Thiel, and Peter Blessington, and Tao Zou, and Danielle Feather, and Xinjiang Wu, and Jizhou Yan, and Hui Zhang, and Zuguo Liu, and Patricia Ernst, and Gary A Koretzky, and Xianxin Hua
November 2021, Oncogenesis,
Austin T Thiel, and Peter Blessington, and Tao Zou, and Danielle Feather, and Xinjiang Wu, and Jizhou Yan, and Hui Zhang, and Zuguo Liu, and Patricia Ernst, and Gary A Koretzky, and Xianxin Hua
October 2010, Haematologica,
Copied contents to your clipboard!